Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03326193
Title Phase 2, A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Mobile Alabama 36604 United States Details
GSK Investigational Site Anchorage Alaska 99508 United States Details
GSK Investigational Site Mesa Arizona 85284 United States Details
GSK Investigational Site Burbank California 91505 United States Details
GSK Investigational Site Los Angeles California 90095 United States Details
GSK Investigational Site Fort Myers Florida 33908 United States Details
GSK Investigational Site Saint Petersburg Florida 33705 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site Detroit Michigan 48202 United States Details
GSK Investigational Site Jackson Mississippi 39216 United States Details
GSK Investigational Site Columbia Missouri 65212 United States Details
GSK Investigational Site Kansas City Missouri 64132 United States Details
GSK Investigational Site Kansas City Missouri 66205 United States Details
GSK Investigational Site Lebanon New Hampshire 03756 United States Details
GSK Investigational Site Englewood New Jersey 07631 United States Details
GSK Investigational Site Morristown New Jersey 07962-1956 United States Details
GSK Investigational Site Summit New Jersey 07962-1956 United States Details
GSK Investigational Site Albany New York 12208 United States Details
GSK Investigational Site Rochester New York 14642 United States Details
GSK Investigational Site Asheville North Carolina 28816 United States Details
GSK Investigational Site Columbus Ohio 43214 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15224 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Chattanooga Tennessee 37403 United States Details
GSK Investigational Site Kingsport Tennessee 37660 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field